Schering recall
Executive Summary
Certain lots of Schering-Plough's Proventil albuterol inhalers, Warrick generic albuterol inhalers and Vanceril (beclomethasone) 42 mcg and 84 mcg inhalers manufactured before Sept. 30, 1999 are being voluntarily recalled because some products may not contain the active drug, the company announced March 29. The recall stems from manufacturing problems noted in October. Vanceril was also recalled in December for the same reason (1"The Pink Sheet" Dec. 6, 1999, In Brief). The most recent inspection of the aerosol line at the Kenilworth, N.J. facility was completed in February, the company said
You may also be interested in...
CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time
FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products
CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time
FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products
Schering-Plough Vanceril
Recall issued for 82,000 units of beclomethasone 84 mcg double strength inhalation aerosol convenience pack for the treatment of asthma after Schering discovered that the inhalers may not contain active drug